Anchor Investment Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-233
Closed -$9.6K 1048
2021
Q4
$9.6K Hold
233
﹤0.01% 792
2021
Q3
$10.8K Hold
233
﹤0.01% 710
2021
Q2
$9.31K Sell
233
-136
-37% -$5.82K ﹤0.01% 735
2021
Q1
$19.8K Sell
369
-2
-0.5% -$115 ﹤0.01% 629
2020
Q4
$18.2K Hold
371
﹤0.01% 608
2020
Q3
$12.1K Hold
371
﹤0.01% 627
2020
Q2
$9.61K Hold
371
﹤0.01% 642
2020
Q1
$9.02K Hold
371
﹤0.01% 636
2019
Q4
$10.4K Buy
+371
New +$9.6K ﹤0.01% 641

Other funds holding VCYT

Anchor Investment Management's VCYT Position: Q1 2022 in Review

Anchor Investment Management sold out of Veracyte (VCYT) in Q1 2022, closing a stake of 233 shares — an estimated $9.6K sold.

Anchor Investment Management first reported a position in VCYT in Q4 2019 and held it in 9 quarters. The position peaked at $19.8K in Q1 2021. 205 funds tracked by Wall St. Rank hold VCYT as of Q1 2022.

  • Anchor Investment Management reported no remaining Veracyte position as of Q1 2022 after selling out during the quarter.
  • Anchor Investment Management sold 233 Veracyte shares in Q1 2022, an estimated $9.6K.
  • Anchor Investment Management first reported a position in Veracyte in Q4 2019 and held it in 9 quarters.
  • Anchor Investment Management's Veracyte position peaked at $19.8K in Q1 2021.
  • 205 funds tracked by Wall St. Rank held Veracyte as of Q1 2022.

Based on Anchor Investment Management's 13F filing for Q1 2022, filed 2 Jan 2024.